Shearman & Sterling advised Boston Scientific Corporation, as borrower, on a $2 billion unsecured term loan facility agented by Barclays Bank PLC to refinance the outstanding commitments under a bridge credit agreement and to finance the acquisition of BTG plc, a company which acquires, develops, manufactures and commercializes pharmaceutical products internationally. Shearman & Sterling also advised Boston Scientific Corporation, as borrower, on a $2.75 billion unsecured revolving credit facility agented by Wells Fargo Bank, National Association.

Boston Scientific Corporation, headquartered in Marlborough, MA, develops, manufactures and markets medical devices for use in various interventional medical specialties worldwide.

The Team